Anti-parasitic Drug Ivermectin Reduces COVID-19 Transmission

Anti-parasitic Drug Ivermectin Reduces COVID-19 Transmission


Anti-parasitic Drug Ivermectin Reduces COVID-19 Transmission
by Karishma Abhishek on 
January 20, 2021 at 9:05 PM
Early administration of Ivermectin can decrease the viral loads and symptom duration in patients with mild COVID-19. This may in turn lead to reduce viral transmission as per a small pilot study which is part of the SAINT project and has been led by the University of Navarra Clinic and the Barcelona Institute for Global Health (ISGlobal) published in the journal
EClinicalMedicine, The Lancet.
"Many efforts are focusing on developing treatments for COVID-19, but few are addressing how to reduce viral transmission," says study coordinator Carlos Chaccour, researcher at ISGlobal and physician at the University of Navarra Clinic.

Related Keywords

, University Of Navarra Clinic , Barcelona Institute For Global Health Isglobal , Navarra Clinic , Barcelona Institute , Global Health , Covid 19 , Ivermectin , Viral Loads , Symptom , Infections , Early Administration , Rviral Transmission , பல்கலைக்கழகம் ஆஃப் நாவார சிகிச்சையகம் , நாவார சிகிச்சையகம் , பார்சிலோனா நிறுவனம் , உலகளாவிய ஆரோக்கியம் , வைரஸ் சுமைகள் , அறிகுறி , நோய்த்தொற்றுகள் , வைரஸ் பரவும் முறை ,

© 2025 Vimarsana